Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANGE trial of cilostazol add-on therapy in acute ischemic stroke due to large artery atherosclerosis
KCT0010177Phase 4Recruiting
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in ischemic stroke, large artery atherosclerosis (LAA), sponsored by Korea Otsuka Pharmaceutical. Started Jul 2025; status: recruiting.
02
Drugs
cilostazol
03
Conditions
ischemic strokelarge artery atherosclerosis (LAA)
Beyond the preview
Go deeper on KCT0010177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010177.